Abstract:Purpose: Glial fibrillary acidic protein serves as a biomarker indicative of astroglial injury, particularly following instances of severe traumatic brain injury. This study aims to evaluate variations in serum glial fibrillary acidic protein levels within the first 3 days and their correlation with outcomes in patients with severe traumatic brain injury. Subjects and methods: Thirty-nine patients with severe traumatic brain injury were enrolled in the study. Their blood samples were collected at six distinct time points: T0 (upon admission), T1, T2, T3, T4, and T5 (6-, 12-, 24-, 48-, and 72-h post-admission, respectively). The blood samples were run for the quantification of serum glial fibrillary acidic protein levels and other biochemical tests. All patients were closely watched and the outcomes at discharge were evaluated. Results: Glial fibrillary acidic protein levels tend to increase gradually from the time of admission to 48 h post-admission and then decrease at 72 h post-admission. Glial fibrillary acidic protein T2 is correlated with Acute Physiology and Chronic Health Evaluation II score, lactate, Simplified Acute Physiology Score II score and outcome. Glial fibrillary acidic protein max correlated with lactate, Acute Physiology and Chronic Health Evaluation II score, Simplified Acute Physiology Score II score, and outcome. Glasgow Coma Score at admission and glial fibrillary acidic protein T2 (OR = 1.034; p = 0.025), T3 (OR = 1.029; p = 0.046), T4 (OR = 1.006; p = 0.032), T5 (OR = 1.012; p = 0.048) and glial fibrillary acidic protein max (OR = 1.005; p = 0.010) were independent factors that have significant prognostic value in mortality in patients with severe traumatic brain injury. The predictive model in predicting mortality had the highest area under the curve based on glial fibrillary acidic protein T2 and Glasgow Coma Score T0 with an area under the curve of 0.904 and p < 0.001. In the multivariable regression model, glial fibrillary acidic protein max was associated with Glasgow score (p < 0.001; VIF = 1.585), lactate T0 (p = 0.024; VIF = 1.163), Acute Physiology and Chronic Health Evaluation II score (p = 0.037; VIF = 1.360), and Rotterdam score (p = 0.044; VIF = 1.713). Conclusion: Glial fibrillary acidic protein levels tend to increase gradually from the time of admission to 48 h post-admission then decreases at 72 h post-admission. Glial fibrillary acidic protein T2, T3, T4, T5, and glial fibrillary acidic protein max were independent factors with significant prognostic mortality values in patients with severe traumatic brain injury.

Neuroglobin and Nogo-a as biomarkers for the severity and prognosis of traumatic brain injury.

Serum Albumin And Prealbumin Predict The Poor Outcome Of Traumatic Brain Injury

Serum netrin-1 as a potential biomarker for functional outcome of traumatic brain injury

Change of serum Nogo-A protein in patients with acute closed brain injury

Relationship between cerebrospinal fluidα-Synuclein and prognosis of patients with traumatic brain injury

Amyloid-β Protein and Neuroglobin Protein as Biomarkers on Brainstem Following Traumatic Brain Injury in Rats

Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients

Glial Fibrillary Acidic Protein As a Biomarker in Severe Traumatic Brain Injury Patients: a Prospective Cohort Study

Role of Α-Ii-spectrin Breakdown Products in the Prediction of the Severity and Clinical Outcome of Acute Traumatic Brain Injury.

Role of Diffusion Tensor Imaging Combined with Neuron-Specific Enolase and S100 Calcium-binding Protein B Detection in Predicting the Prognosis of Moderate and Severe Traumatic Brain Injury

Neutrophil-albumin ratio serves as a superior prognostic biomarker for traumatic brain injury

Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis

Serum Biomarkers and Disease Progression in CT-negative Mild Traumatic Brain Injury.

Lactic Acid, Neuron-Specific Enolase, and Blood-Brain Barrier Index after a Severe Traumatic Brain Injury: a Prospective Study

Relationship study between serum brain red protein content and the de-gree of nerve injury in patients with brain injury

Analysis of the Risk of Traumatic Brain Injury and Evaluation Neurogranin and Myelin Basic Protein As Potential Biomarkers of Traumatic Brain Injury in Postmortem Examination

Neutrophil to Lymphocyte Ratio As a Novel Predictor of Outcome in Patients with Severe Traumatic Brain Injury.

Serum Neuron Specific Enolase and Matrix Metalloproteinases in Patients with Severe Traumatic Brain Injury and the Clinical Significance

Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury

Changes in the levels of serum glial fibrillary acidic protein and the correlation with outcomes in severe traumatic brain injury patients

BNP and NT-proBNP Concentrations in Paired cerebrospinal Fluid and Plasma Samples of Patients with Traumatic Brain Injury